Stock data
Sana Biotechnology, Inc. (SANA)
Sana Biotechnology, Inc. (SANA) reported net income of -US$244.17M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$250.32M | -US$244.17M | — |
| 2024 | — | — | -US$272.72M | -US$266.76M | — |
| 2023 | — | — | -US$293.14M | -US$283.25M | — |
| 2022 | — | — | -US$272.56M | -US$269.48M | — |
| 2021 | — | — | -US$356.91M | -US$355.93M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$63.63M | — |
| 2026-03-31 | — | -US$47.21M | — |
| 2025-12-31 | — | -US$58.83M | — |
| 2025-09-30 | — | -US$42.15M | — |
| 2025-06-30 | — | -US$93.80M | — |
| 2025-03-31 | — | -US$49.39M | — |
| 2024-12-31 | — | -US$49.07M | — |
| 2024-09-30 | — | -US$59.92M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.